Vaccine makers reduce research efforts and lay off employees
As of October 2023, Pfizer has confirmed the elimination of approximately 2,000 jobs, primarily within its research and development divisions. Similarly, Moderna has indicated a 25% reduction in its workforce, a move that reflects the company’s need to adjust to a post-pandemic market. These decisions come at a time when funding for vaccine research is … Read more
